A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer to Emergent.
{iframe}https://www.fiercepharma.com/vaccines/emergent-biosolutions-and-valneva-s-zika-vaccine-turns-up-positive-early-phase-data{/iframe}